CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
批准号:
10942871
负责人:
LEYI GONG
金额:
$32.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-27 至 2024-09-26
关键词:
AdenomyosisArchivesBacterial InfectionsBiologicalChemicalsContraceptive AgentsContraceptive methodsDataDatabasesDown SyndromeDysmenorrheaEquipmentEquipment and supply inventoriesFetal Growth RetardationFibroid TumorGestational DiabetesGynecologicHealthInfertilityInflammationLactationMaintenanceMissionMuscular DystrophiesNational Institute of Child Health and Human DevelopmentNatural ProductsNecrotizing EnterocolitisPelvic PainPerinatalPituitary-dependent Cushing&aposs diseasePlacentaPolycystic Ovary SyndromePolymersPre-EclampsiaPremature BirthProductionReproductive HealthResearchRett SyndromeRoleSepsisUnited States National Institutes of HealthVirus DiseasesVulvodyniaautism spectrum disorderdrug developmentendometriosisimprovedin vivo evaluationmastitismicrobiomenovelscreeningsmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This task is to conduct the core administrative activities, including project management, as well as storage of chemical and biological inventory, archived documents and data, maintenance of equipment, and continued database maintenance activities in the Chemical Screening and Optimization Facility (CSOF) to support the mission of contraceptive drug development in the Contraception Research Branch (CRB), NICHD, NIH.
The Chemical Screening and Optimization Facility (CSOF) fulfills a unique role by identifying, optimizing and conducting production identified small molecules for contraceptive and reproductive health related (e.g., infertility, polycystic ovarian syndrome, fibroids, endometriosis, dysmenorrhea, adenomyosis, gynecologic and/or pelvic pain, and vulvodynia, premature birth, placenta health, improving lactation quality and quantity, preeclampsia, perinatal microbiome, gestational diabetes, inflammation, bacterial infections, viral infections, necrotizing enterocolitis, bronchopulmonary dyplasia, pre-term birth, fetal growth restriction, mastitis, Cushing's disease, Down Syndrome, Ricketts, Muscular Dystrophy, Rett syndrome, sepsis, or Autism) research. One approach is to conduct scalable quantity projects of identified small molecule(s) (e.g., natural product) and/or large molecule (e.g., polymer) that afford a contraceptive effect against a validated target or as a treatment for an identified reproductive health related indication. This facility will also be responsible for the production of chemical material for preliminary in vivo testing. It is expected that multiple independent projects will be performed simultaneously by the CSOF. Appropriate oversight of these projects will be essential for their successful execution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN EXPRESSION AND/OR X-RAY CRYSTALLOGRAPHY
-
批准号:10942884
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2023
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES
-
批准号:10942882
-
项目类别:
-
资助金额:$77.32万
-
财政年份:2023
-
负责人:LEYI GONG
-
依托单位:
Task B28: Efficacy Studies for Therapeutics Development
-
批准号:10703289
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2022
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY (CSOF) – DRUG AND SUBSTANCE
-
批准号:10710754
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2022
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY (CSOF) - CHEMICAL OPTIMIZATION APPROACHES
-
批准号:10710755
-
项目类别:
-
资助金额:$43.44万
-
财政年份:2022
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY- HIGH THROUGHPUT SCREENING
-
批准号:10421851
-
项目类别:
-
资助金额:$88.97万
-
财政年份:2021
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "STRUCTURE ACTIVITY RELATIONSHIPS"
-
批准号:10274476
-
项目类别:
-
资助金额:$96.73万
-
财政年份:2020
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - "SCALABLE QUANTITIES OFACTIVE PHARMACEUTICAL INGREDIENTS"
-
批准号:10274475
-
项目类别:
-
资助金额:$20.14万
-
财政年份:2020
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN GENERATION
-
批准号:10022550
-
项目类别:
-
资助金额:$17.11万
-
财政年份:2019
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - STRUCTURE ACTIVITY RELATIONSHIPS
-
批准号:10022551
-
项目类别:
-
资助金额:$116.79万
-
财政年份:2019
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
-
批准号:10706293
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2018
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
-
批准号:10021516
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2018
-
负责人:LEYI GONG
-
依托单位:
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
-
批准号:10263135
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2018
-
负责人:LEYI GONG
-
依托单位:
海外基金